Trinad Capital L.P.
CIK 1289378 · last filed 2014-03-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MNDL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
3RD FLOOR
LOS ANGELES, CA 90010
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Digital Turbine, Inc. (MNDL) Delisted | 10%+ Owner | 5,316,158 | — | — | -$16.91M | 2 | 2014-03-07 |
| Protagenic Therapeutics, Inc.\new (ATRN) Delisted | 10%+ Owner | 50 | — | — | $2.67M | 1 | 2010-01-07 |
| Protagenic Therapeutics, Inc.\new (NWMO) Delisted | 10%+ Owner | 2,313,170 | — | — | $856.4K | 2 | 2008-09-03 |
| COMMAND SECURITY CORP (MOC) Delisted | 10%+ Owner | 2,639,078 | — | — | $1.27M | 1 | 2007-09-13 |
Recent Filings · Page 2 of 3
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-10-31 | — | Buy (P) | +1,803,600 | $232.7K | |
| 2008-10-23 | — | Buy (P) | +41,400 | $26.9K | |
| 2008-10-02 | — | Buy (P) | +127,200 | $28.0K | |
| 2008-09-18 | — | Buy (P) | +3,850,800 | $893.9K | |
| 2008-09-12 | — | Buy (P) | +233,112 | $236.4K | |
| 2008-09-03 | Protagenic Therapeutics, Inc.\new (NWMO) Delisted | Buy (P) | +150,000 | $603.9K | EDGAR |
| 2008-06-09 | Protagenic Therapeutics, Inc.\new (NWMO) Delisted | Buy (P) | +60,000 | $252.4K | EDGAR |
| 2008-06-04 | — | Buy (P) | +180,000 | $237.5K | |
| 2008-03-31 | — | Buy (P) | +175,800 | $12.2K | |
| 2008-03-27 | — | Buy (P) | +1,041,678 | $1.04M |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.